Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Xenomics, a molecular diagnostics company, has appointed Thomas Adams as its new chairman of the board.
Subscribe to our email newsletter
Dr Adams is the co-founder of a number of successful diagnostic and pharmaceutical companies including Genprobe, Hybritech, Genta and Leucadia Technologies. Dr Adams is a senior executive of Iris which acquired Leucadia Technologies.
Dr Adams said: “Xenomics trans-renal DNA disease detection diagnostic platform offers significant advantages over conventional tests. The company is using this platform to create truly diagnostic applications that are only achievable using Xenomics’s patented trans-renal technology.”